Early dropout after one month of buprenorphine/naloxone maintenance therapy

Journal Title: New Medicine - Year 2011, Vol 15, Issue 2

Abstract

Introduction. Suboxone (Buprenorphine/naloxone) is a drug used in opiate substitu­tion therapy. In Hungary, it was introduced in November 2007. Suboxone is a product for sublingual administration containing the partial p-receptor agonist buprenorphine and antagonist naloxone in a 4:1 ratio. Aim. Objectives of our study were to monitor and evaluate the psychosocial changes after one month of Suboxone treatment. Material and methods. 6 outpatient centres participated in the study; 3 from Budapest and 3 from smaller cities in Hungary. At these centres, all patients entering Suboxone maintenance therapy between November 2007 and March 2008, totalling 80 persons (55 males, 35 females, mean age = 30,2 years, SD=5,48) were included in the study sample. During the 6-month period of treatment, data were col­lected 4 times; when entering treatment, 1 month, 3 months, and 6 months after entering treatment. Applied measure was the Addiction Severity Index. Results. Nearly fourth of the total of 80 heroin dependent patients (18 persons, 22.5%) dropped out of treatment during the first month (the majority, 12 persons [15%] during the first week) or chose methadone substitution instead. During the first month of treatment significant positive changes were observed in all studied psychological and behavioural dimensions and proved to be stable throughout the studied period. Conclusions. According to the experience with Suboxone treatment, it is a well tolerable and successfully applicable drug in the substitution therapy of opiate addicts. A critical phase seems to be the first one or two weeks of treatment. Dropout rate is high during this early period, whereas after a successful conversion patients presumably remain in therapy for a long period. At the beginning of administration special emphasis must be put on informing patients, especially concern­ing withdrawal symptoms that might be present during the first week, which highly contributes to better retention in treatment.

Authors and Affiliations

Zsolt Petke, Judit Mészáros, István Vingender, Zsuzsanna Kovács, Zsuzsa Menczel, Anna Havasi, Péter Simor, József Rácz

Keywords

Related Articles

The influence of exocyclic DNA adducts in bacterial and mammalian genome instability

Oxidative stress enhances lipid peroxidation (LPO) implicated in the promotion and progression of carcinogenesis. One of the major LPO products is <i>trans</i>-4-hydroxy-2-nonenal (HNE), may t...

History of research on depression: biomolecular considerations and philosophical reflections

Recent studies have demonstrated the existence of significant differences in fatty acid composition of the cell membranes of platelets between depressed humans and apparently healthy subjects.These differences were ident...

Intimacy and privacy during childbirth. a pilot-study testing a new self-developed questionnaire: the childbirth intimacy and privacy scale (CIPS)

Introduction. Based on the findings of academic literature, evidence has found that physical and social environment play an inherent role in the birthing procedure. Birth is a natural process, with a specific sequence of...

Comparing health conditions of homeless clients in Budapest day-care centres

Aim. Diótörés Foundation has carried out a complex health condition study among 100 volunteering homeless people – part of the program supported by The Norwegian Found - which aimed at getting correct diagnosis and prope...

Download PDF file
  • EP ID EP55219
  • DOI -
  • Views 135
  • Downloads 0

How To Cite

Zsolt Petke, Judit Mészáros, István Vingender, Zsuzsanna Kovács, Zsuzsa Menczel, Anna Havasi, Péter Simor, József Rácz (2011). Early dropout after one month of buprenorphine/naloxone maintenance therapy. New Medicine, 15(2), -. https://europub.co.uk/articles/-A-55219